- clinical trial, diagnostics, epidemiology, filarial parasites, global health, infectious disease, lymphatic filariasis, onchocerciasis, risk factors & disease risk, soil & water quality, tropical diseases
Dr. Weil leads a group conducts population-based epidemiology studies and clinical trials in Africa and Asia, the Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Project. They also develop and evaluate diagnostic tests for helminth parasite infections (lymphatic filariasis, river blindness and intestinal worm infections) that are major public health problems in the developing world.
In August 2015, Dr. Weil received $7 million in support from the Bill & Melinda Gates Foundation to continue his work, funding 12 field projects in eight countries in Africa and the Asia-Pacific region.
Dr. Weil was the recipient of the 2016 Anne Maurer-Cecchini Award, which recognizes outstanding epidemiological or clinical research on neglected tropical diseases, given at the Geneva Health Forum in April 2016.